FDA Webview
X
about-us-banner

FDA Related News

Home / Articles / FDA Related News
FDA General

Senate Confirms Hahn as Next FDA Commissioner

The Senate confirms Stephen Hahn as the next FDA commissioner on a floor vote of 72-18.

Medical Devices

Newborn Test for Duchennes Cleared for Use

FDA authorizes the de novo marketing of PerkinElmers GSP Neonatal Creatine Kinase-MM kit as an aid in newborn screening for Duchenne Muscular Dystroph...

Human Drugs

Elite Pharmaceuticals ANDA for Generic Adderall XR

FDA approves an Elite Pharmaceuticals ANDA for a generic version of Shires Adderall XR, indicated for treating attention deficit hyperactivity disorde...

Human Drugs

House Passes Drug Pricing Bill

The House approves drug pricing legislation that is likely to die in the Senate or face a presidential veto.

Human Drugs

Provention Bio Plans Rolling BLA for 2020

Provention Bio says it is planning a rolling BLA application for its Type 1 diabetes drug teplizumab in 2020.

Human Drugs

Draft Pediatric Oncology Studies Guidance

FDA publishes for comment a draft guidance on early planning for pediatric evaluation of certain molecularly targeted oncology drugs.

Federal Register

Briviact Injection/Solution Regulatory Review Period

Federal Register notice: FDA has determined for patent extension purposes the regulatory review period for Briviact oral solution and separately for a...

Medical Devices

Cochlear Osia 2 Hearing Implant Cleared

FDA clears a Cochlear Ltd. 510(k) for the Cochlear Osia 2 System, an active osseointegrated steady-state hearing implant.

Marketing

Vivitrol Ad Omits Risk Information: OPDP

The CDER Office of Prescription Drug Promotion warns Alkermes about a misleading Vivitrol print ad that omits important risk information.

Human Drugs

Xolair sBLA for Treating Nasal Polyps

FDA accepts for review a Novartis supplemental BLA for Xolair (omalizumab) for treating nasal polyps in adult patients who do not respond well to intr...